Clinical trial
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe…
NCT00409682 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00409682 |
|---|---|
| Title | Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease |
| Official title | A Multi-Center, Double-Blind Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Biological |
| Interventions | Adalimumab |
| Enrollment | 192 |
| Start date | Apr 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Dec 11, 2006 |
| Last update posted | Aug 4, 2011 |
| Countries | Belgium, Canada, Czechia, France, Netherlands, Poland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: